Education
About Us
Working with TipRanks
Follow Us
Revolution Medicines (RVMD)
NASDAQ:RVMD
RVMD Analyst Ratings
Strong Buy
12 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
RVMD Stock 12 Month Forecast
Average Price Target
$69.82
▲(83.25% Upside)
| Highest Price Target$78.00 | Average Price Target$69.82 | Lowest Price Target$59.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bank of America Securities
Reiterated
03/26/25
H.C. Wainwright
Reiterated
02/28/25
J.P. Morgan
Reiterated
02/27/25
Oppenheimer
Reiterated
02/27/25
TD Cowen
Reiterated
02/27/25
Piper Sandler
Reiterated
02/27/25
Needham
Reiterated
02/27/25
Wedbush
Reiterated
02/27/25
Stifel Nicolaus
Reiterated
02/27/25
Leerink Partners
Reiterated
02/27/25
Barclays
$72
Buy
88.98%
Upside
Reiterated
02/27/25
Analysts Are Bullish on Top Healthcare Stocks: Amneal Pharmaceuticals (AMRX), Revolution Medicines (RVMD)
UBS
$65→$71
Buy
86.35%
Upside
Reiterated
01/08/25
Revolution Medicines price target raised to $71 from $65 at UBSRevolution Medicines price target raised to $71 from $65 at UBS
Jefferies
$86
Buy
125.72%
Upside
Reiterated
12/20/24
Jefferies Keeps Their Buy Rating on Revolution Medicines (RVMD)
Guggenheim
$82→$87
Buy
128.35%
Upside
Reiterated
12/03/24
Revolution Medicines price target raised to $87 from $82 at GuggenheimRevolution Medicines price target raised to $87 from $82 at Guggenheim
Raymond James
$48
Buy
25.98%
Upside
Reiterated
09/12/24
Revolution Medicines added to Analyst Current Favorites list at Raymond JamesRevolution Medicines added to Analyst Current Favorites list at Raymond James
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bank of America Securities
Reiterated
03/26/25
H.C. Wainwright
Reiterated
02/28/25
J.P. Morgan
Reiterated
02/27/25
Oppenheimer
Reiterated
02/27/25
TD Cowen
Reiterated
02/27/25
Piper Sandler
Reiterated
02/27/25
Needham
Reiterated
02/27/25
Wedbush
Reiterated
02/27/25
Stifel Nicolaus
Reiterated
02/27/25
Leerink Partners
Reiterated
02/27/25
Barclays
$72
Buy
88.98%
Upside
Reiterated
02/27/25
Analysts Are Bullish on Top Healthcare Stocks: Amneal Pharmaceuticals (AMRX), Revolution Medicines (RVMD)
UBS
$65→$71
Buy
86.35%
Upside
Reiterated
01/08/25
Revolution Medicines price target raised to $71 from $65 at UBSRevolution Medicines price target raised to $71 from $65 at UBS
Jefferies
$86
Buy
125.72%
Upside
Reiterated
12/20/24
Jefferies Keeps Their Buy Rating on Revolution Medicines (RVMD)
Guggenheim
$82→$87
Buy
128.35%
Upside
Reiterated
12/03/24
Revolution Medicines price target raised to $87 from $82 at GuggenheimRevolution Medicines price target raised to $87 from $82 at Guggenheim
Raymond James
$48
Buy
25.98%
Upside
Reiterated
09/12/24
Revolution Medicines added to Analyst Current Favorites list at Raymond JamesRevolution Medicines added to Analyst Current Favorites list at Raymond James
RVMD Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
1
5
9
18
15
Buy
28
31
19
8
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
29
36
28
26
16
Each month's total comprises the sum of three months' worth of ratings.
RVMD Financial Forecast
RVMD Stock Forecast FAQ
What is RVMD’s average 12-month price target, according to analysts?
Based on analyst ratings, Revolution Medicines’s 12-month average price target is $69.82.
What is RVMD’s upside potential, based on the analysts’ average price target?
Revolution Medicines has 83.25% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is RVMD a Buy, Sell or Hold?
Revolution Medicines has a consensus rating of Strong Buy which is based on 12 buy ratings, 0 hold ratings and 0 sell ratings.
What is Revolution Medicines’s price target?
The average price target for Revolution Medicines is $69.82. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $78.00 ,the lowest forecast is $59.00. The average price target represents 83.25% Increase from the current price of $38.1.
The highest analyst price target is $78.00 ,the lowest forecast is $59.00. The average price target represents 83.25% Increase from the current price of $38.1.
What do analysts say about Revolution Medicines?
Revolution Medicines’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of RVMD?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.